Fresenius AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fresenius SE & Co KGAA O.N. (FREn)
Fresenius SE & Co KGAA O.N. stock price live, this page displays ETR FREn stock exchange data. View the FREn premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Fresenius SE & Co KGAA O.N. real time stock price chart below.
What Is the Fresenius SE & Co KGAA O.N. Stock Price Today?
The Fresenius SE & Co KGAA O.N. stock price today is 46.6450.
What Is the Stock Symbol for Fresenius SE & Co KGAA O.N.?
The stock symbol for Fresenius SE & Co KGAA O.N. is "FREn."
What Stock Exchange Does Fresenius SE & Co KGAA O.N. Trade On?
Fresenius SE & Co KGAA O.N. is listed and trades on the Xetra stock exchange.
Is Fresenius SE & Co KGAA O.N. a Good Stock to Buy?
Determining whether Fresenius SE & Co KGAA O.N.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FREn quote. (ISIN: DE0005785604)
What Is the Fresenius SE & Co KGAA O.N. Stock Price Today?
The Fresenius SE & Co KGAA O.N. stock price today is 46.6450.
What Is the Stock Symbol for Fresenius SE & Co KGAA O.N.?
The stock symbol for Fresenius SE & Co KGAA O.N. is "FREn."
What Stock Exchange Does Fresenius SE & Co KGAA O.N. Trade On?
Fresenius SE & Co KGAA O.N. is listed and trades on the Xetra stock exchange.
Is Fresenius SE & Co KGAA O.N. a Good Stock to Buy?
Determining whether Fresenius SE & Co KGAA O.N.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FREn quote. (ISIN: DE0005785604)
46.645
-0.085(-0.18%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
46.515
47.395
52 wk Range
35.110
52.960
FREn is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
46.51547.395
52 wk Range
35.11052.960
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.25%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.25%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
FREn Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
55.862
Upside
+19.76%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings upwards for the upcoming period
Fresenius AG receives Investment Bank Analyst Rating Update- Investing.com
Pro
Fresenius AG receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Fresenius AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Fresenius AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Fresenius AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Fresenius AG receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Fresenius AG receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
13 Buy
1 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 55.862
(+19.76% Upside)
Earnings
Latest Release
Aug 04, 2026
EPS / Forecast
0.83 / 0.87
Revenue / Forecast
5.95B / 5.82B
Compare FREn to Peers and Sector
Metrics to compare | FREn | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFREnPeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.8x | 20.7x | −0.3x | |
PEG Ratio | 0.48 | 0.19 | 0.00 | |
Price/Book | 1.3x | 2.1x | 2.6x | |
Price / LTM Sales | 1.1x | 1.9x | 3.1x | |
Upside (Analyst Target) | 19.8% | 8.8% | 48.5% | |
Fair Value Upside | Unlock | 20.3% | 6.3% | Unlock |
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company has a strategic collaboration with SAP SE and Avelios Medical GmbH for the development of a cloud-native, modular hospital information system that enables digitalization of clinical and administrative processes with AI integration. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Fresenius SE (FREn) Stock Price Today?
The Fresenius SE stock price today is 46.645 EUR.
What Stock Exchange Does Fresenius SE Trade On?
Fresenius SE is listed and trades on the Frankfurt Stock Exchange.
What Is the Stock Symbol for Fresenius SE?
The stock symbol for Fresenius SE is "FREn."
Does Fresenius SE Pay Dividends? What’s The Current Dividend Yield?
The Fresenius SE dividend yield is 2.25%.
What Is the Fresenius SE Market Cap?
As of today, Fresenius SE market cap is 26.270B EUR.
When Is the Next Fresenius SE Earnings Date?
Fresenius SE will release its next earnings report on Nov 04, 2026.
From a Technical Analysis Perspective, Is FREn a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Fresenius SE Stock Split?
Fresenius SE has split 4 times.
How Many Employees Does Fresenius SE Have?
Fresenius SE has 178486 employees.
What is the current trading status of Fresenius SE (FREn)?
As of Aug 20, 2026, Fresenius SE (FREn) is trading at a price of 46.645 EUR, with a previous close of 46.645 EUR. The stock has fluctuated within a day range of 46.515 EUR to 47.395 EUR, while its 52-week range spans from 35.110 EUR to 52.960 EUR.
What Is Fresenius SE (FREn) Price Target According to Analysts?
The average 12-month price target for Fresenius SE is 55.862 EUR, with a high estimate of 63.5 EUR and a low estimate of 50 EUR. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +19.76% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.